The Efficacy and Safety of Insulin Degludec/Liraglutide Combination (IDegLira) in Patients With Type 2 Diabetes
Clinical trial NCT06408532 · UNKNOWN
Trial details
- NCT number
- NCT06408532
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-30
- Primary completion
- 2024-10-30
- Enrollment
- 256
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.